meenal datta
University of Notre Dame
Notre Dame, United States
Associate Editor
Cancer Immunity and Immunotherapy
Type at least 3 characters
Editors
Shape the future of research in your field
Join the board
Associate Editors
thomas daubon
UMR5095 Institut de Biochimie et Génétique Cellulaires (IBGC)
Bordeaux, France
Associate Editor
Cancer Molecular Targets and Therapeutics
adil daud
University of California, San Francisco
San Francisco, United States
Associate Editor
Skin Cancer
diwakar davar
University of Pittsburgh Medical Center
Pittsburgh, United States
Associate Editor
Skin Cancer
naval daver
University of Texas MD Anderson Cancer Center
Houston, United States
Associate Editor
Hematologic Malignancies
marco davila
Moffitt Cancer Center
Tampa, United States
Associate Editor
Cancer Immunity and Immunotherapy
lara e. davis
Oregon Health and Science University
Portland, United States
Associate Editor
Pediatric Oncology
nancy b davis
Merck Sharp & Dohme Corp (United States)
West Point, United States
Associate Editor
Genitourinary Oncology
carlos e de andrea
University of Navarra
Pamplona, Spain
Associate Editor
Cancer Immunity and Immunotherapy
carmine de angelis
University of Naples Federico II
Naples, Italy
Associate Editor
Breast Cancer
marco de bruyn
University Medical Center Groningen
Groningen, Netherlands
Associate Editor
Cancer Immunity and Immunotherapy
marianna de camargo cancela
National Cancer Institute (INCA)
Rio de Janeiro, Brazil
Associate Editor
Cancer Epidemiology and Prevention
andrea de giglio
University of Bologna
Bologna, Italy
Associate Editor
Thoracic Oncology
adolfo de la fuente
MD Anderson Cancer Center Madrid
Madrid, Spain
Associate Editor
Hematologic Malignancies
thibault de la motte rouge
Centre Eugène Marquis
Rennes, France
Associate Editor
Gynecological Oncology
ivana de la serna
University of Toledo Medical Center
Toledo, United States
Associate Editor
Cancer Molecular Targets and Therapeutics